Icosavax, Inc. (ICVX): Price and Financial Metrics
ICVX Price/Volume Stats
| Current price | $15.31 | 52-week high | $16.10 |
| Prev. close | $15.45 | 52-week low | $4.75 |
| Day low | $15.28 | Volume | 9,315,200 |
| Day high | $15.44 | Avg. volume | 1,215,776 |
| 50-day MA | $15.08 | Dividend yield | N/A |
| 200-day MA | $10.06 | Market Cap | 766.88M |
ICVX Stock Price Chart Interactive Chart >
Icosavax, Inc. (ICVX) Company Bio
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-A12, an respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-121, a vaccine candidate with RSV target; IVX-241, a vaccine candidate with hMPV target; IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2^ target indication; and IVX-421, a variant RBD antigen with SARS-CoV-2^ target indication. The company was incorporated in 2017 and is headquartered in Seattle, Washington.
ICVX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -1.86% |
| 3-year | -31.93% |
| 5-year | N/A |
| YTD | -2.86% |
| 2023 | 98.49% |
| 2022 | -65.30% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...